400 filings
Page 14 of 20
6-K
dweumq28377 nxt71m2
12 Jun 17
Acasti Pharma To Present at Upcoming International Industry Conferences
12:00am
6-K
lcpd8d dl2
6 Jun 17
Acasti Pharma Reports Fourth Quarter and Full-Year 2017 Financial Results
12:00am
6-K
y619lhl3 heizwzn
6 Jun 17
Acasti Pharma Inc. 6-K
12:00am
6-K
qdhd3z7en damrilj
31 May 17
Acasti Pharma and CordenPharma Announce Large Scale Production of CaPreĀ® with New Continuous Manufacturing Process
12:00am
6-K
be1sr uj3l7y
18 May 17
Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions
12:00am
6-K
94lpwk5m 4y7
24 Apr 17
Acasti Pharma Inc. 6-K
12:00am
6-K
oqrdeic3d6cgm
12 Apr 17
Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions
12:00am
6-K
xo4zhkmrz ww
30 Mar 17
Acasti Pharma Provides Update On CaPre Phase 3 Development Program
12:00am
6-K
w8212 dn3
8 Mar 17
Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease Experts
12:00am
6-K
i5az5pn cclgrft
28 Feb 17
Acasti Pharma Announces Closings of Concurrent Public Offering of Units and Private Placement of Convertible Debentures and Warrants
12:00am
6-K
1435gu
24 Feb 17
Acasti Pharma Inc. 6-K
12:00am
6-K
dngi2ws
21 Feb 17
Current report (foreign)
12:00am
6-K
li8g9t st1uuyro7
12 Jan 17
Current report (foreign)
12:00am
6-K
flh83er
12 Jan 17
Acasti Pharma Reports Third Quarter 2017 Financial Results
12:00am
6-K
taz1yruo3r
5 Dec 16
Current report (foreign)
12:00am
6-K
lc9kmmk cp
28 Nov 16
Acasti Pharma Appoints Linda O'Keefe as Chief Financial Officer
12:00am
6-K
disdad
3 Nov 16
Acasti Announces Stock Ticker Symbol Change to ACST on the TSXV
12:00am
6-K
l7rwe2i
26 Oct 16
Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre
12:00am
6-K
0lbrtb6l0246bfs smdw
11 Oct 16
Current report (foreign)
12:00am
6-K
5suxrt1n 3qx8vv3
11 Oct 16
Acasti Pharma Reports Second Quarter 2017 Financial Results
12:00am